Compare Mesoblast Limited (MESO) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Skyworks Solutions Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Skyworks Solutions Inc trades at $62.99 (market cap $8.99B). The key difference: Skyworks Solutions Inc is far larger — about 4.1× Mesoblast Limited's market cap, and Skyworks Solutions Inc pays a 4.75% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | SWKS | |
|---|---|---|
Market Cap | $2.17B | $8.99B |
Sector | Technology | Technology |
52-Week High | $20.96 | $83.40 |
52-Week Low | $12.88 | $52.50 |
Enterprise Value | $2.17B | $8.76B |
Dividend Yield | — | 4.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
